Cargando…
Commentary to “Mogamulizumab‐induced photosensitivity in patients with mycosis fungoides and other T‐cell neoplasms” by Y. Masuda et al.
Linked article: This is a commentary on Y. Masuda et al., pp. 1456–1460 in the previous issue. To view this article visit https://doi.org/10.1111/jdv.14797
Autor principal: | Hönigsmann, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221007/ https://www.ncbi.nlm.nih.gov/pubmed/30303306 http://dx.doi.org/10.1111/jdv.15214 |
Ejemplares similares
-
Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy
por: Fujimura, Taku, et al.
Publicado: (2018) -
Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome
por: Beylot‐Barry, Marie, et al.
Publicado: (2022) -
PB2345: MOGAMULIZUMAB IN MYCOSIS FUNGOIDES AND SÈZARY SYNDROME: AN ITALIAN SINGLE CENTER EXPERIENCE
por: Simula, Maria Pina, et al.
Publicado: (2023) -
Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma
por: Muszbek, Noemi, et al.
Publicado: (2023) -
Mycosis Fungoides with Photosensitivity Mimicking Chronic Actinic Dermatitis
por: Sinha, Anwita, et al.
Publicado: (2020)